Multiplexed CRISPR gene editing in primary human islet cells with Cas9 ribonucleoprotein
R. J. Bevacqua, W. Zhao, E. Merheb, S. H. Kim, A. Marson, A. L. Gloyn, S. K. Kim
This study uses CRISPR/Cas9 RNP to edit regulatory DNA elements in human islet cells, revealing their role in diabetes risk and β cell function.
iScience · Jan 1, 2024Peer-reviewedCell Biology